- Filed
- Jul 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jul 10, 2025 | 15.77M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 14.56M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2025 | 14.72M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 14.2M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 13.65M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $398.53K |
| Capex | Q3 2025 · Mar 31, 2025 | $245.36K |
| Capex | Q3 2025 · Mar 31, 2024 | $1.65M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2025 | −$7.34M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$7.32M |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $6.96M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $1.86M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $91.95M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $92.55M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $100.1M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $111.75M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $122.08M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $125.37M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $63.96M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $61.29M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $70.92M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $63.15M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $124.77M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $127.69M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $162.87M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $163.25M |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$0.06 |
| Eps Diluted | Q3 2025 · Mar 31, 2025 | −$0.53 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.79 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$1.32 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$0.06 |
| Eps Basic | Q3 2025 · Mar 31, 2025 | −$0.53 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.79 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$1.32 |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $3.84M |
| Sga Expense | Q3 2025 · Mar 31, 2025 | $14.11M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $15.46M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $26.96M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$875.22K |
| Net Income | Q3 2025 · Mar 31, 2025 | −$7.85M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$10.9M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$18.06M |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$599.22K |
| Operating Income | Q3 2025 · Mar 31, 2025 | −$7.16M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$10.97M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$18.15M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $4.96M |
| Gross Profit | Q3 2025 · Mar 31, 2025 | $12.41M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $6.34M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $14.32M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $19.83M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2025 | $44.09M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $26.6M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $58.82M |